Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI

American Journal of Roentgenology

Volumn 203, Issue 4, 2014, Pages W408-W414

  Agarwal, Sheela ^a   Fuentes Orrego, Jorge M ^a   Arnason, Thomas ^b   Misdraji, Joseph ^a   Jhaveri, Kartik S ^c   Harisinghani, Mukesh ^a   Hahn, Peter F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Contrast enhanced MRI; Gadoxetate disodium; Inflammatory hepatocellular adenoma; Liver imaging

Indexed keywords

GADOXETIC ACID; GLUTAMATE AMMONIA LIGASE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY HEPATOCELLULAR ADENOMA; LIVER ADENOMA; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; CONTRAST-ENHANCED MRI; DIFFERENTIAL DIAGNOSIS; HEPATITIS; IMAGE ENHANCEMENT; LABORATORY DIAGNOSIS; LIVER IMAGING; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CONTRAST-ENHANCED MRI; GADOXETATE DISODIUM; INFLAMMATORY HEPATOCELLULAR ADENOMA; LIVER IMAGING;

ADENOMA, LIVER CELL; ADULT; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HEPATITIS; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84910109332     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.12251     Document Type: Article

References (30)

1. Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979; 242:644-648
2. Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI on distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010; 32:138-147
3. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological and pathological correlations. Hepatology 1995; 22:1674-1681
4. Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011; 60:85-89
5. Bioulac-Sage P, Cubel G, Taouli S, et al. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 2012; 36:1691-1699
6. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48:163-170
7. Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 262:520-529
8. Bieze M, van den Esschert JW, Nio CY, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the value of gadoxetate disodium. AJR 2012; 199:26-34
9. Bioulac-Sage P, Cubel G, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010; 27:39-45
10. Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46:140-146
11. Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, MR imaging findings with histopathologic correlation in 13 cases. Radiology 2003; 228:465-472
12. Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Pathol Res Int 2011; 2011:403929
13. Hechtman JF, Raoufi M, Fiel MI, et al. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol 2011; 35:927-932
14. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systemic review including more than 1600 adenoma cases. HBP (Oxford) 2010; 12:509-522
15. Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137:1698-1705
16. th ed. Philadelphia, PA: Churchill Livingston Elsevier, 2012
17. Shafizadeh N, Kakar S. Diagnosis of well differentiated hepatocellular lesions: role of immunohistochemistry and any other ancillary techniques. Adv Anat Pathol 2011; 18:438-445
18. Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol 2013; 2013:417323
19. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006; 16:1873-1886
20. Gupta RT, Iseman CM, Leyendecker JM, Shyknevsky I, Merkle EM, Taouli B. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR 2012; 199:35-43
21. Denecke T, Steffen IG, Agarwal S, et al. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 2012; 22:1769-1775
22. Ringe KI, Husarik DB, Sirlin CB, Merkle EM. Gadoxetate disodium-enhanced MRI of the liver. Part 1. Protocol optimization and lesion appearance in the noncirrhotic liver. AJR 2010; 195:13-28
23. Giovanoli O, Heim M, Terraciano L, Bongartz G, Ledermann HP. MRI of hepatic adenomatosis: initial observations with gadoxetic contrast agent in three patients. AJR 2008; 190:[web]W290-W293
24. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48:808-818
25. van Aalten SM, Thomeer MGJ, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 2011; 261:172-181
26. Vander Borght S, Libbrecht L, Blokzijl H, et al. Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 2005; 207:471-482
27. Grazioli L, Olivetti L, Mazza G, Bondioni MP. MR imaging of hepatocellular adenomas and diagnosis dilemma. Int J Hepatol 2013; 2013:374170
28. Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int 2008; 2:316-321
29. Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 2012; 32:1217-1221
30. Bioulac-Sage P, Sempoux C, Possenti L, et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol 2013; 2013:253261